These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 4218834)
1. Proceedings: The defect in Maroteaux-Lamy disease (mucopolysaccharidosis VI, subtype A): deficiency of N-acetylgalactosamine-4-sulfatase. O'Brien JF; Spranger J; Cantz M Hoppe Seylers Z Physiol Chem; 1974 Oct; 355(10):1235. PubMed ID: 4218834 [No Abstract] [Full Text] [Related]
2. [The early diagnosis of Maroteaux-Lamy syndrome with confirmation of arylsulphatase deficiency]. Van Biervliet JP; Van Leeuwen EF; Abeling NG; De Jonge HF; Liem KO; Wadman SK Arch Fr Pediatr; 1977 Apr; 34(4):362-70. PubMed ID: 142458 [TBL] [Abstract][Full Text] [Related]
3. Maroteaux-Lamy disease (mucopolysaccharidosis VI), subtype A: deficiency of a N-acetylgalactosamine-4-sulfatase. O'Brien JF; Cantz M; Spranger J Biochem Biophys Res Commun; 1974 Oct; 60(3):1170-7. PubMed ID: 4215420 [No Abstract] [Full Text] [Related]
4. Arylsulphatase B (Maroteaux-Lamy factor): a part of the enzyme system responsible for sulphate release from mucopolysaccharide fragment. Gniot-Szulzycka J; Donnelly PV FEBS Lett; 1976 May; 65(1):63-8. PubMed ID: 819304 [No Abstract] [Full Text] [Related]
6. Uridine diphospho-N-acetylgalactosamine-4-sulfate sulfohydrolase activity of human arylsulfatase B and its deficiency in the Maroteaux-Lamy syndrome. Fluharty AL; Stevens RL; Fung D; Peak S; Kihara H Biochem Biophys Res Commun; 1975 Jan; 64(3):955-62. PubMed ID: 238522 [No Abstract] [Full Text] [Related]
7. Deficiency of arylsulfatase B in 2 brothers aged 40 and 38 years (Maroteaux-Lamy syndrome, type B). Pilz H; von Figura K; Goebel HH Ann Neurol; 1979 Oct; 6(4):315-25. PubMed ID: 122048 [TBL] [Abstract][Full Text] [Related]
8. Human N-acetylgalactosamine-4-sulphatase biosynthesis and maturation in normal, Maroteaux-Lamy and multiple-sulphatase-deficient fibroblasts. Taylor JA; Gibson GJ; Brooks DA; Hopwood JJ Biochem J; 1990 Jun; 268(2):379-86. PubMed ID: 2114091 [TBL] [Abstract][Full Text] [Related]
9. N-acetylgalactosamine-4-sulfatase: identification of four new mutations within the conserved sulfatase region causing mucopolysaccharidosis type VI. Simonaro CM; Schuchman EH Biochim Biophys Acta; 1995 Dec; 1272(3):129-32. PubMed ID: 8541342 [TBL] [Abstract][Full Text] [Related]
10. Prenatal diagnosis of Maroteaux-Lamy syndrome. Van Dyke DL; Fluharty AL; Schafer IA; Shapiro LJ; Kihara H; Weiss L Am J Med Genet; 1981; 8(2):235-42. PubMed ID: 6792921 [TBL] [Abstract][Full Text] [Related]
11. An index case for the attenuated end of the mucopolysaccharidosis type VI clinical spectrum. Brooks DA; Gibson GJ; Karageorgos L; Hein LK; Robertson EF; Hopwood JJ Mol Genet Metab; 2005 Jul; 85(3):236-8. PubMed ID: 15979036 [TBL] [Abstract][Full Text] [Related]
12. Arylsulphatase B studies in skin fibroblasts from patients with Maroteaux--Lamy syndrome with special reference to electrophoretic mobility and prenatal diagnosis. Schwartz M; Brandt NJ; Christensen E; Pedersen C J Inherit Metab Dis; 1980; 3(3):99-100. PubMed ID: 6775150 [No Abstract] [Full Text] [Related]
13. [Mucopolysaccharidosis type VI (Maroteaux-Lamy syndrome)]. Sukegawa K; Tomatsu S; Kondo N; Orii T Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):446-8. PubMed ID: 9645105 [No Abstract] [Full Text] [Related]
14. An N-acetylgalactosamine-4-sulfatase mutation (delta G238) results in a severe Maroteaux-Lamy phenotype. Litjens T; Morris CP; Robertson EF; Peters C; von Figura K; Hopwood JJ Hum Mutat; 1992; 1(5):397-402. PubMed ID: 1301949 [TBL] [Abstract][Full Text] [Related]
15. Deficiency of chondroitin sulfate N-acetylgalactosamine 4-sulfate sulfatase in Maroteaux-Lamy syndrome. Matalon R; Arbogast B; Dorfman A Biochem Biophys Res Commun; 1974 Dec; 61(4):1450-7. PubMed ID: 4218107 [No Abstract] [Full Text] [Related]
16. Mucopolysaccharidosis in a cat with arylsulfatase B deficiency: a model of Maroteaux-Lamy syndrome. Jezyk PF; Haskins ME; Patterson DF; Mellman WJ; Greenstein M Science; 1977 Nov; 198(4319):834-6. PubMed ID: 144321 [TBL] [Abstract][Full Text] [Related]
18. [Maroteaux-Lamy syndrome: a case report]. Mtar A; Charfeddine B; Braham I; Ben Abdallah J; Neffati S; Smach MA; Bourfifa Z; Ksouri M; Dridi H; Limem K Ann Biol Clin (Paris); 2011; 69(6):693-7. PubMed ID: 22123570 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis of Maroteaux-Lamy syndrome by the use of radiolabelled oligosaccharides as substrates for the determination of arylsulphatase B activity. Hopwood JJ; Elliott H; Muller VJ; Saccone GT Biochem J; 1986 Mar; 234(3):507-14. PubMed ID: 3087346 [TBL] [Abstract][Full Text] [Related]
20. Direct comparison of measures of endurance, mobility, and joint function during enzyme-replacement therapy of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): results after 48 weeks in a phase 2 open-label clinical study of recombinant human N-acetylgalactosamine 4-sulfatase. Harmatz P; Ketteridge D; Giugliani R; Guffon N; Teles EL; Miranda MC; Yu ZF; Swiedler SJ; Hopwood JJ; Pediatrics; 2005 Jun; 115(6):e681-9. PubMed ID: 15930196 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]